A. Bikov (Budapest, Hungary), F. Garcia-Cosio Piqueras (Palma de Mallorca, Spain), J. Lopez-Campos Bodineau (Sevilla, Spain)
A study to assess airway remodelling and the utility of low dose CT scoring to evaluate the asthmatic airway. E. Hunt (Cork, Ireland)
| |
An 12-week, Randomised, Parallel-group, Phase III Study comparing the Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg and Twice-daily Budesonide Swinghaler 200 µg During Step-down in Well Controlled Asthma N. Nakwan (Songkhla, Thailand)
| |
Time to move away from peak flows in severe asthma? A symptom based score that predicts exacerbations. D. Neville (Portsmouth, United Kingdom)
| |
Exhaled nitric oxide and blood eosinophilia: biomarkers of different adult asthma phenotypes H. Coumou (Amsterdam, Netherlands)
| |
An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP) A. Lexmond (Groningen, Netherlands)
| |
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels C. Lake (Camperdown, NSW, Australia)
| |
Point-of-care blood eosinophils count in a severe asthma clinic setting E. Heffler (Torino, To, Italy)
| |
Factors associated with poor asthma control in the year prior to students' first year at university H. Burhan (Liverpool, United Kingdom)
| |
Concordance between Asthma Control Test and the revised GINA criteria of asthma control K. Schultz (Bad Reichenhall, Germany)
| |
Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study M. Kallieri (Aspropyrgos, Greece)
| |
Moleculer characterization of severe allergic asthma patients via exhaled breath volatile organic compounds(Ege University Translational Pulmonology Research Group [EgeTPRG]) O. Goksel (Izmir, Bornova, Turkey)
| |
Cluster analysis of severe life-threatening asthma: identification of a distinct phenotype characterized by high serum eosinophils P. Lau (Singapore, Singapore)
| |
Migration status as a risk factor for adult-onset asthma R. Aarab (Amsterdam, Netherlands)
| |
Predictors of sputum and BAL eosinophilia in the Wessex Severe Asthma Cohort T. Jones (Portsmouth, United Kingdom)
| |
Multiple breath nitrogen washout test and methacholine challenge test in clinical suspicion of asthma. A. Siebeneichler (PORTO ALEGRE/ RS, Brazil)
| |
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? A. Haccuria (Brussels, Belgium)
| |
Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab M. Mukherjee (Hamilton, ON, Canada)
| |